Osteoarthritis (OA) is a degenerative joint disease caused by chronic inflammation that
damages articular cartilage. At present, the treatment of OA includes drug therapy to relieve …

Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …

Osteoarthritis (OA) has traditionally been known as a “wear and tear” disease, which is
mainly characterized by the degradation of articular cartilage and changes in the …

Background: In diseased joints, the catabolic environment results in progressive joint
damage. Mesenchymal stem cells (MSCs) can have immunomodulatory effects by secreting …

Mesenchymal stem cells (MSCs) have great potential to differentiate into various types of
cells, including but not limited to, adipocytes, chondrocytes and osteoblasts. In addition to …

Osteoarthritis (OA) is a multifaceted disease characterized by imbalances in extracellular
matrix metabolism, chondrocyte and synoviocyte senescence, as well as inflammatory …

Mesenchymal stem cell (MSC) therapy represents a promising approach for the treatment of
osteoarthritis (OA). MSCs can be readily isolated from multiple sources and expanded ex …

Osteoarthritis (OA) is a degenerative disease of the connective tissue and progresses with
age in the older population or develops in young athletes following sports-related injury. The …

The prevalence of osteoarthritis (OA), a degenerative disorder of joints, has substantially
increased in recent years. Its key pathogenic hallmarks include articular cartilage …

Mesenchymal stem cells (MSCs) are multipotent stem cells that are able to immunomodulate
cells from both the innate and the adaptive immune systems promoting an anti‐inflammatory …